| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.2 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.077 | 0.2 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.21 | 0.2 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.2 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.2 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.059 | 0.2 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |